Search Results - Carlos A. Barrero
- Showing 1 - 2 results of 2
-
1
CRISPR/Cas9-Based Screening of FDA-Approved Drugs for NRF2 Activation: A Novel Approach to Discover Therapeutics for Non-Alcoholic Fatty Liver Disease by James Li, Sandra Arest, Bartlomiej Olszowy, John Gordon, Carlos A. Barrero, Oscar Perez-Leal
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Posiphen Reduces the Levels of Huntingtin Protein through Translation Suppression by Xu-Qiao Chen, Carlos A. Barrero, Rodrigo Vasquez-Del Carpio, E. Premkumar Reddy, Chiara Fecchio, Salim Merali, Alessia Deglincerti, Cheng Fang, Jack Rogers, Maria L. Maccecchini
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book